Utility of Artificial Intelligence in Antibiotic Development: Accelerating Discovery in the Age of Resistance

Antimicrobial resistance (AMR) is a growing public health issue, complicating the treatment of bacterial infections and increasing morbidity and mortality globally. This phenomenon, which occurs as a result of the ability of bacteria to adapt and evade conventional treatments, requires innovative strategies to address it. Artificial intelligence (AI) emerges as a transformative tool in this context, helping accelerate the identification of molecules with antimicrobial potential and optimize the design of new drugs. This article analyzes the usefulness of AI in antibiotic development, highlighting its benefits in terms of time, cost, and efficiency in the fight against resistant bacteria, as well as the challenges associated with its implementation in the biomedical field.